Darren Sherman - 26 Aug 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: President and Chief Operating Officer, Director
Issuer ticker: OBIO
Reported as of: 26 Aug 2026
Net transaction value: +$10,660
SEC form: 4
Accepted by SEC: 28 Aug 2026, 16:15:51 UTC
Prior SEC filing: 04 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Taylor, Attorney-in-Fact

Key filing fact

Darren Sherman filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 28 Aug 2026.

Key facts

This page summarizes Darren Sherman's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Aug 2026, 16:15.

Change

Previous filing in this sequence was filed on 04 Aug 2026.
Current net transaction value: +$10,660.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001723524 Primary reporting owner

Sherman Darren

Relationship: President and Chief Operating Officer, Director
Address: C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Signature date: 28 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OBIO transaction

Common Stock, par value $0.0001 per share ("Common Stock")

Tax liability

Transaction value
Shares: -4,925
Change %: -0.43%
Price: $5.26^*
Shares after: 1,149,402
Date: 26 Aug 2026
Ownership: Direct
Footnotes: F1

OBIO transaction

Common Stock

Purchase

Transaction value: $10,660
Shares: +2,000
Change %
Price: $5.33
Shares after: 2,000
Date: 26 Aug 2026
Ownership: By son
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Footnote F2

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC remarks

President and Chief Operating Officer